"( 1 )Represents issuance of stock for payment of approximately 33% of Dr. Armen's base salary for April 2013.
( 2 )Dr. Armen is trustee and has investment authority for the Garo Armen 2009 4 Year GRAT and the Garo Armen 2012 2 Year GRAT, holding 292,122 and 500,000 shares of Agenus Inc. common stock, respectively. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is also Chairman of the Board of managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership of his pecuniary interest therein."
Thanks. Funny how this stock was manipulated down so insiders could buy cheap shares. 146% increase in PFS in Glioblastomas is all I needed to see yesterday to know where this stock is headed over the coming months.